Gastrointestinal prokinetic therapy: Serotonergic drugs

Robert J. Washabau, Jean A. Hall

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

Gastrointestinal prokinetic therapy is becoming increasingly important in small animal practice. The first four parts of this five-part Continuing Education series group gastrointestinal prokinetic drugs into four categories; for each category, the mechanisms of action, site of activity, and indications are considered. Part I provided information on the dopaminergic antagonist drugs. Part II dealt with motilin-like drugs. This article, which is Part III, discusses serotonergic drugs, especially cisapride. Part IV will deal with the acetylcholinesterase inhibitors or parasympathetic potentiating drugs. The concluding article will consider the diagnosis and treatment of esophageal, gastric, and colonic motility disorders. Cisapride stimulates gastrointestinal motility at a dosage of 0.1 to 1.0 mg/kg orally every 8 to 12 hours. It is superior to metoclopramide in the treatment of gastroesophageal reflux, delayed gastric emptying, ileus, and constipation. At a dose of 0.6 to 2.6 mg/kg, cisapride may be useful as an antiemetic for patients receiving cis-platinum chemotherapy if other 5-HT3 antagonists are unavailable.

Original languageEnglish (US)
Pages (from-to)473-480
Number of pages8
JournalCompendium on Continuing Education for the Practicing Veterinarian
Volume19
Issue number4
StatePublished - Apr 1 1997

Fingerprint

Cisapride
Serotonin Agents
drug therapy
drug
drugs
Motilin
Serotonin 5-HT3 Receptor Antagonists
Gastrointestinal Agents
Dopamine Agents
Metoclopramide
Gastrointestinal Motility
Antiemetics
Dopamine Antagonists
Ileus
Gastric Emptying
Cholinesterase Inhibitors
Continuing Education
Constipation
Gastroesophageal Reflux
antagonists

Cite this

Gastrointestinal prokinetic therapy : Serotonergic drugs. / Washabau, Robert J.; Hall, Jean A.

In: Compendium on Continuing Education for the Practicing Veterinarian, Vol. 19, No. 4, 01.04.1997, p. 473-480.

Research output: Contribution to journalReview article

@article{905552e4a72343e48b91347ab53a662c,
title = "Gastrointestinal prokinetic therapy: Serotonergic drugs",
abstract = "Gastrointestinal prokinetic therapy is becoming increasingly important in small animal practice. The first four parts of this five-part Continuing Education series group gastrointestinal prokinetic drugs into four categories; for each category, the mechanisms of action, site of activity, and indications are considered. Part I provided information on the dopaminergic antagonist drugs. Part II dealt with motilin-like drugs. This article, which is Part III, discusses serotonergic drugs, especially cisapride. Part IV will deal with the acetylcholinesterase inhibitors or parasympathetic potentiating drugs. The concluding article will consider the diagnosis and treatment of esophageal, gastric, and colonic motility disorders. Cisapride stimulates gastrointestinal motility at a dosage of 0.1 to 1.0 mg/kg orally every 8 to 12 hours. It is superior to metoclopramide in the treatment of gastroesophageal reflux, delayed gastric emptying, ileus, and constipation. At a dose of 0.6 to 2.6 mg/kg, cisapride may be useful as an antiemetic for patients receiving cis-platinum chemotherapy if other 5-HT3 antagonists are unavailable.",
author = "Washabau, {Robert J.} and Hall, {Jean A.}",
year = "1997",
month = "4",
day = "1",
language = "English (US)",
volume = "19",
pages = "473--480",
journal = "Compendium on Continuing Education for the Practicing Veterinarian",
issn = "0193-1903",
publisher = "Veterinary Learning Systems",
number = "4",

}

TY - JOUR

T1 - Gastrointestinal prokinetic therapy

T2 - Serotonergic drugs

AU - Washabau, Robert J.

AU - Hall, Jean A.

PY - 1997/4/1

Y1 - 1997/4/1

N2 - Gastrointestinal prokinetic therapy is becoming increasingly important in small animal practice. The first four parts of this five-part Continuing Education series group gastrointestinal prokinetic drugs into four categories; for each category, the mechanisms of action, site of activity, and indications are considered. Part I provided information on the dopaminergic antagonist drugs. Part II dealt with motilin-like drugs. This article, which is Part III, discusses serotonergic drugs, especially cisapride. Part IV will deal with the acetylcholinesterase inhibitors or parasympathetic potentiating drugs. The concluding article will consider the diagnosis and treatment of esophageal, gastric, and colonic motility disorders. Cisapride stimulates gastrointestinal motility at a dosage of 0.1 to 1.0 mg/kg orally every 8 to 12 hours. It is superior to metoclopramide in the treatment of gastroesophageal reflux, delayed gastric emptying, ileus, and constipation. At a dose of 0.6 to 2.6 mg/kg, cisapride may be useful as an antiemetic for patients receiving cis-platinum chemotherapy if other 5-HT3 antagonists are unavailable.

AB - Gastrointestinal prokinetic therapy is becoming increasingly important in small animal practice. The first four parts of this five-part Continuing Education series group gastrointestinal prokinetic drugs into four categories; for each category, the mechanisms of action, site of activity, and indications are considered. Part I provided information on the dopaminergic antagonist drugs. Part II dealt with motilin-like drugs. This article, which is Part III, discusses serotonergic drugs, especially cisapride. Part IV will deal with the acetylcholinesterase inhibitors or parasympathetic potentiating drugs. The concluding article will consider the diagnosis and treatment of esophageal, gastric, and colonic motility disorders. Cisapride stimulates gastrointestinal motility at a dosage of 0.1 to 1.0 mg/kg orally every 8 to 12 hours. It is superior to metoclopramide in the treatment of gastroesophageal reflux, delayed gastric emptying, ileus, and constipation. At a dose of 0.6 to 2.6 mg/kg, cisapride may be useful as an antiemetic for patients receiving cis-platinum chemotherapy if other 5-HT3 antagonists are unavailable.

UR - http://www.scopus.com/inward/record.url?scp=0006973207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0006973207&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0006973207

VL - 19

SP - 473

EP - 480

JO - Compendium on Continuing Education for the Practicing Veterinarian

JF - Compendium on Continuing Education for the Practicing Veterinarian

SN - 0193-1903

IS - 4

ER -